QA: ENDONOVO THERAPEUTICS INC. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001528172_2020_ENDONOVO_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001528172')"}

Graph

Absolute values for 0001528172, ENDONOVO THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 62,555
1 IntangibleAssetsNetIncludingGoodwill 3,206,180
2 PropertyPlantAndEquipmentNet 5,915
3 remainder_Assets 0
4 LiabilitiesCurrent 23,623,470
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 155,000
7 CostOfGoodsAndServicesSold 93,385
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 4,025,851
11 remainder_Revenues 310,164
12 remainder_NetIncome -13,505,432
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,274,650
1 Liabilities 23,778,470
2 Expenses 4,119,236
3 Revenues 310,164
4 StockholdersEquity -20,503,820
5 NetIncome -17,314,504
6 ComprehensiveNetIncome -17,314,504
7 BaseVar 22,493,976
8 EconomicCapitalRatio -3.89

Edgar->Model Mapping

Feature Distribution

Change over Time